20191 ⎘
Medicinal preparations containing organic active ingredients Halogenated hydrocarbons
Sub-classes:RED SEAWEED FEED PRODUCTS AND METHODS FOR PROCESSING RED SEAWEED
#2NANO2 DODECAFLUOROPENTANE EMULSION AS A CARDIAC ARREST THERAPEUTIC
#3COMPOSITIONS CONTAINING VERTEPORFIN, RIBAVIRIN, GEMCITABINE, OR COMBINATIONS THEREOF AND METHODS OF USE FOR TREATING COVID-19, CANCER, OR NON CANCER DISEASES
#4SEMIFLUORINATED ALKANE TETRACYCLINE COMBINATION COMPOSITIONS FOR TREATMENT OF MALAR EDEMA
#5COMPOSITIONS AND METHODS FOR REDUCING GREENHOUSE GAS
#6COMPOSITIONS CONTAINING VERTEPORFIN, RIBAVIRIN, GEMCITABINE, OR COMBINATIONS THEREOF AND METHODS OF USE FOR TREATING COVID-19, CANCER, OR NON CANCER DISEASES
#7METHODS OF INDUCING ANESTHESIA
#8COMPOSITION COMPRISING A MIXTURE OF AT LEAST ONE OIL AND ONE OR MORE SEMIFLUORINATED ALKANES, A USE OF THE COMPOSITION FOR TREATING A DISEASE AS WELL AS A METHOD OF PRODUCING THE COMPOSITION AND CORRESPONDING KITS
#9OPHTHALMIC COMPOSITIONS FOR TREATMENT OF OCULAR SURFACE DAMAGE AND SYMPTOMS OF DRYNESS
#10DEVICES AND METHODS FOR DELIVERING METHANE INHIBITING COMPOUNDS TO ANIMALS
#11FLUOROCHEMICAL TARGETED THERAPIES
#12COMPOSITIONS OF FLUOROCARBON NANOEMULSION, AND METHODS OF PREPARATION AND USE THEREOF
#13NOVEL COMPOSITIONS FOR REDUCING METHANE PRODUCTION IN RUMINANT ANIMALS
#14COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR
#15METHODS
#16COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR
#17SEMIFLUORINATED COMPOUNDS AND THEIR COMPOSITIONS
#18ORAL MUCOSAL CARRIER AND PROTECTANT
#19SILK FIBROIN-CONTAINING COMPOSITION AND METHODS OF USE THEREOF
#20DEVICES AND METHODS FOR DELIVERING METHANE INHIBITING COMPOUNDS TO ANIMALS
#21ISO-OSMOTIC AND NEAR ISO-OSMOTIC OXYGEN THERAPEUTIC FORMULATIONS AND METHODS THEREOF
#22COMPOSITIONS COMPRISING MIXTURES OF SEMIFLUORINATED ALKANES
#23NOVEL FLUOROCHEMICAL CARDIAC RESUSCITATION
#24COMPOSITIONS AND METHODS FOR REDUCING GREENHOUSE GAS
#25COMPOSITIONS AND METHODS FOR REDUCING GREENHOUSE GAS
#26COMPOSITIONS AND METHODS FOR REDUCING GREENHOUSE GAS
#27A WATER SOLUBLE OR WATER DISPERSIBLE BOLUS ARTICLE CONTAINING BROMOFORM
#28A WATER-SOLUBLE GLASS RUMEN BOLUS
#29A WATER SOLUBLE OR WATER DISPERSIBLE BOLUS ARTICLE
#30COMPOSITIONS CONTAINING VERTEPORFIN, RIBAVIRIN, GEMCITABINE, OR COMBINATIONS THEREOF AND METHODS OF USE FOR TREATING COVID-19, CANCER, OR NON CANCER DISEASES
#31STABILISED COMPOSITIONS
#32FRACTIONATED RADIOTHERAPY AND CHEMOTHERAPY WITH AN OXYGEN THERAPEUTIC
#33OPTHALMIC COMPOSITIONS COMPRISING F6H8
#34METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF POST-OPERATIVE COGNITIVE DYSFUNCTION
#35FLUOROCARBON COMPOSITIONS AND METHODS FOR ENHANCING IMMUNOTHERAPY
#36COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR
#37Devices and methods for delivering methane inhibiting compounds to animals
#38COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR
#39COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR
#40COMPOSITIONS FOR REDUCTION OF OXIDATIVE STRESS, IMPROVEMENT TO THE IMMUNE SYSTEM, PROMOTION OF HEALTHY CARTILAGE AND/OR ALLEVIATION OF PAIN ACCOMPANYING INFLAMMATORY DISEASES IN RUMINANTS
#41MICROFLUIDIC PREPARATION OF FLUOROCARBON NANODROPLETS
#42COMPOSITION FOR INCREASING EXPRESSION OF BLOOD COAGULATION FACTOR GENE, COMPRISING CORE-SHELL STRUCTURED MICROPARTICLES AS ACTIVE INGREDIENT
#43Compounds and methods for the targeted degradation of androgen receptor
#44SEMIFLUORINATED ALKANE COMPOSITIONS
#45SILK PARTICLES ENCAPSULATING OXYGEN CARRIERS AS ARTIFICIAL BLOOD SUBSTITUTE
#46NON-THERAPEUTIC METHODS FOR ALLEVIATING OR REDUCING STRESS SYMPTOMS OF RUMINANTS
#47Methods and Apparatuses for the Synthesis of Drug-Loaded Magnetic Micelle Aggregates
#48COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR
#49COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR
#50PHARMACEUTICAL COMPOSITION FOR USE IN TREATING SUBJECT IN HYPOXIC STATE DUE TO RESPIRATORY FAILURE, ETC.
#51DODECAFLUOROPENTANE EMULSION AS A STROKE AND ISCHEMIA THERAPY
#52Fractionated radiotherapy and chemotherapy with an oxygen therapeutic
#53OTOLOGICAL SURGERY UNDER PERFLUOROCARBON LIQUIDS
#54Methods and pharmaceutical compositions for the treatment of post-operative cognitive dysfunction
#55ANTIPARASITIC COMPOSITION
#56Compositions containing Verteporfin, Ribavirin, Gemcitabine, or combinations thereof and methods of use for treating COVID-19, cancer, or non cancer diseases
#57COMPOSITIONS OF FLUOROCARBON NANOEMULSION, AND METHODS OF PREPARATION AND USE THEREOF
#58ANALGESIC COMPOSITIONS COMPRISING HALOGENATED VOLATILE COMPOUNDS
#59Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor
#60Semifluorinated compounds and their compositions
#61BIOMIMETIC NANOEMULSIONS FOR OXYGEN DELIVERY
#62METHODS FOR GENERATING ANIMAL MODELS FOR NONALCOHOLIC FATTY LIVER DISEASE
#63METHODS OF INDUCING ANESTHESIA
#64Compounds and methods for the targeted degradation of androgen receptor
#65Fluorochemical targeted therapies
#66PRESYNAPTIC GLUTAMATE RELEASE INHIBITORS FOR DECREASING NMDA ANTAGONIST SIDE EFFECTS IN ANESTHESIA
#67Antigen Delivery Vectors and Constructs
#68Method for producing an oil composition
#69Oral mucosal carrier and protectant
#70PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OCULAR NEOVASCULARISATION
#71OPHTHALMIC COMPOSITIONS FOR TREATMENT OF OCULAR SURFACE DAMAGE AND SYMPTOMS OF DRYNESS
#72METHODS OF INDUCING ANESTHESIA
#73SEMIFLUORINATED COMPOUNDS
#74FLUTICASONE AND VILANTEROL FORMULATION AND INHALER
#75Fractionated radiotherapy and chemotherapy with an oxygen therapeutic
#76Systems and methods for monitoring neural activity
#77Ophthalmic compositions comprising tafluprost for the treatment of glaucoma
#78Composition and method for rapidly inducing an endogenous ketosis
#79Compositions containing verteporfin, ribavirin, gemcitabine, or combinations thereof and methods of use for treating COVID-19, cancer, or non cancer diseases
#80Methods and pharmaceutical compositions for the treatment of post-operative cognitive dysfunction
#81Compounds and methods for the targeted degradation of androgen receptor
#82SILK FIBROIN-CONTAINING COMPOSITION AND METHODS OF USE THEREOF
#83Composition for increasing the expression of a growth factor gene, comprising coreshell structured microparticles as active ingredient
#84Analgesic compositions
#85COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR
#86Adjusting particle size in fluorocarbon nanoemulsions
#87Compounds and methods for the targeted degradation of androgen receptor
#88COMPOSITIONS AND METHODS FOR THE REMOVAL OF EAR WAX
#89Methods for the non-therapeutic alleviation or prophylaxis of symptoms of oxidative stress, reduced immune system or cartilage damage of ruminants
#90Non-therapeutic methods for alleviating or reducing stress symptoms of ruminants
#91Semifluorinated compounds and their compositions
#92Scavenging Dissolved Oxygen Via Acoustic Droplet Vaporization
#93Opthalmic compositions comprising F6H8
#94VOLATILE ANESTHETIC COMPOSITIONS COMPRISING EXTRACTIVE SOLVENTS FOR REGIONAL ANESTHESIA AND/OR PAIN RELIEF
#95APPARATUS AND METHODS FOR PRODUCING AND DELIVERING A VAPOUR MEDICAMENT
#96Semifluorinated alkane compositions
#97Compositions comprising mixtures of semifluorinated alkanes
#98Buffered Oxygen Therapeutic
#99Intravascular ultrasound device and methods for avoiding or treating reperfusion injury
#100Compounds and methods for the targeted degradation of androgen receptor
#101Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions
#102Fractionated radiotherapy and chemotherapy with an oxygen therapeutic
#103Analgesic compositions
#104ISO-OSMOTIC AND NEAR ISO-OSMOTIC OXYGEN THERAPEUTIC FORMULATIONS AND METHODS THEREOF
#105Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief
#106COMPOSITIONS COMPRISING A CANNABINOID RECEPTOR BINDING LIGAND
#107CYCLODEXTRIN COMPOSITIONS ENCAPSULATING A SELECTIVE ATP INHIBITOR AND USES THEREOF
#108Topical administration method
#109Pharmaceutical compositions for use in the therapy of blepharitis
#110Systems and methods for gas mixing in ocular surgical equipment
#111Methods for treating or preventing organophosphate poisoning
#112FLUOROCHEMICAL TARGETED THERAPIES
#113DERMAL REJUVENATION COMPOSITIONS AND METHODS
#114Substituted carbonucleoside derivatives useful as anticancer agents
#115Semifluorinated compounds and their compositions
#116Adsorption of fluorinated anesthetics within the pores of molecular crystals
#117METHODS OF INDUCING ANESTHESIA
#118Compositions of fluorocarbon nanoemulsion, and methods of preparation and use thereof
#119Semifluorinated alkane compositions
#120Scavenging dissolved oxygen via acoustic droplet vaporization
#121Method for the treatment or prevention of lower urinary tract symptoms
#122Analgesic compositions
#123DERMAL REJUVENATION COMPOSITIONS AND METHODS
#124Adjusting particle size in fluorocarbon nanoemulsions
#125Theranostic bubble preparation (TB), and method for using same
#126TREATMENT OF ACUTE COMPLICATIONS OF SICKLE CELL DISEASE
#127Compositions and methods for the removal of ear wax
#1285-substituted-5-hydroxy-5-aryl-3-oxo-pentanoate derivatives and their enantiopure forms
#129Methods of inducing anesthesia
#130Compounds and methods for the targeted degradation of androgen receptor
#1314,5-substituted picolinamide and picolinonitrile metabotropic glutamate receptor 2 negative allosteric modulators
#132Compositions comprising mixtures of semifluorinated alkanes
#133Dodecafluoropentane emulsion as a stroke and ischemia therapy
#134Indole-based therapeutics
#135Buffered oxygen therapeutics
#136Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief
#137Cyclodextrin Compositions Encapsulating a Selective ATP Inhibitor and Uses Thereof
#138Anesthesia device and method of controlling hydrogen concentration in a hydrogen-containing anesthesia gas
#139DERMAL REJUVENATION COMPOSITIONS AND METHODS
#140Onychomycosis treatment system and method
#141ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD
#142Substituted carbonucleoside derivatives useful as anticancer agents
#143USE OF HEMOGLOBIN EFFECTORS TO INCREASE THE BIOAVAILABILITY OF THERAPEUTIC GASES
#144Semifluorinated alkane compositions
#145Semifluorinated compounds
#146SEMIFLUORINATED COMPOUNDS AND THEIR COMPOSITIONS
#147Use of cilastatin to reduce the nephrotoxicity of different compounds
#148Methods and devices for non-invasive cerebral and systemic cooling alternating liquid mist/gas for induction and gas for maintenance
#149Composition and method for rapidly inducing an endogenous ketosis
#150Fractionated radiotherapy and chemotherapy with an oxygen therapeutic
#151NANOPARTICLE DELIVERY SYSTEMS FOR CYTOLYTIC PEPTIDE PRODRUGS
#152Methods of inducing anesthesia
#153CARDIOPROTECTANT TO REDUCE DAMAGE FROM HEART ATTACK
#154Onychomycosis treatment apparatus and method
#155APPARATUS AND METHODS FOR PRODUCING AND DELIVERING A VAPOUR MEDICAMENT
#156Analgesic compositions
#157Formulations of Antimicrobial, Antiviral, and Antineoplastic Compounds In Combination With Certain Wavelengths of Light
#158Cyclodextrin compositions encapsulating a selective ATP inhibitor and uses thereof
#159KCNK3 Channel Loss-of-Function Mutants in Familial and Idiopathic Pulmonary Arterial Hypertension
#160Method for the treatment or prevention of lower urinary tract symptoms
#161Semifluorinated alkane compositions
#162Methods of treating ocular disorders using semifluorinated alkanes
#163DERMAL REJUVENATION COMPOSITIONS AND METHODS
#164Methods of inducing sedation
#165Method for the treatment or prevention of lower urinary tract symptoms
#166Antigen delivery vectors and constructs
#167CONTAINER AND PHARMACEUTICAL PRODUCT
#168Buffered oxygen therapeutic
#169Methods and devices for non-invasive cerebral and systemic cooling
#170CONTRACEPTIVE COMPOSITIONS AND METHODS OF CONTRACEPTION
#171Pharmaceutical composition for administration to nails
#172Cross-linked polymere
#173DODECAFLUOROPENTANE EMULSION AS A STROKE AND ISCHEMIA THERAPY
#174TREATMENT OF RESPIRATORY DISEASES
#175Buffered oxygen therapeutic
#176Methods and devices for non-invasive cerebral and systemic cooling alternating liquid mist/gas for induction and gas for maintenance
#177Dermal rejuvenation compositions and methods
#178Antigen delivery vectors and constructs
#179Methods and Compounds Useful to Induce Apoptosis in Cancer Cells
#180Methods and apparatus for drug modeling and displaying drug models
#181Formulations of volatile anesthetics and methods of use for reducing inflammation
#182Methods and devices for treatment of migraines
#183Perfluorocarbons for use in treating pruritus
#184Novel method for creating, suspending and stabilizing electronically modified oxygen derivatives, along with creating, suspending and stabilizing electronically modified reaction intermediates, in a bio compatible fluorocarbon suspension, for the purpose of inducing a cascading immune response in mammalian patients
#185PROLONGED DURATION LOCAL ANESTHESIA WITH MINIMAL TOXICITY
#186Antigen delivery vectors and constructs
#187Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief
#188Use of cilastatin to reduce nephrotatoxicity of various compounds
#189KIT OF TAMPONING LIQUIDS AND A METHOD FOR THE TREATMENT OF TEARS AND/OR DETACHMENTS OF THE RETINA USING SUCH LIQUIDS
#190Methods and compounds useful to induce apoptosis in cancer cells
#191Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief
#192Methods and devices for treatment of migraines
#193METHOD FOR THE TREATMENT OR PREVENTION OF LOWER URINARY TRACT SYMPTOMS
#194Optimized fluorocarbon emulsions for blood substitutes and other therapeutic uses
#195Peptidomimetic macrocycles with improved properties
#196Emulsions of Perfluorocarbons
#197Therapeutic and cosmetic compositions for treatment of skin
#198Methods
#199Methods and devices for non-invasive cerebral and systemic cooling
#200Antigen delivery vectors and constructs
#201Antigen delivery vectors and constructs
#202Method of treating traumatic brain injury
#203Methods of improving therapy of perfluorocarbons (PFC)
#204Methods of treating parkinson's disease using halogenated volatile compounds
#205MEDICAL ARTICLES FOR THE TREATMENT OF TUMORS
#206Intestinal absorptive anti-tumor agent
#207Methods and devices for non-invasive cerebral and systemic cooling
#208Methods and apparatus for drug modeling and displaying drug models
#209Carcinogen Solvents in Reducing the Carcinogen Concentration of Cells
#210Preventive/Therapeutic Composition For Free Radical Disease
#211Topical treatment or prevention of ocular infections
#212Methods for Delivering Volatile Anesthetics for Regional Anesthesia and/or Pain Relief
#213METHODS FOR INHIBITING THE PRODUCTION OF TSST-1
#214Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
#215Methods and devices for treatment of migraines
#216Partially-fluorinated ethers, compositions and uses thereof, for long-term tamponade in the eye
#217Method for treating a mammal by administration of a compound having the ability to release CO
#218Medical emulsion of perfluororganic compounds and method for the production thereof
#219Treatment of respiratory diseases
#220Methods and devices for non-invasive cerebral and systemic cooling
#221Inhalation Drug Combinations
#222Inhalation Drug Combinations
#223Method of treating herpes viral infections using a halogenated hydrocarbon composition
#224Method for treatment and chemoprevention of prostate cancer
#225Methods and devices for non-invasive cerebral and systemic cooling
#226Biodegradable medical devices with enhanced mechanical strength and pharmacological functions
#227Systemic oxygenation via gastric perfusion with perfluorocarbon (PFC)
#228Oxygenating agents for enhancing host responses to microbial infections
#229Peripheral benzodiazepine receptor independent superoxide generation
#230Method
#231Intra-tracheal application of vascular endothelial growth factor (VEGF) for the prevention of lung damages caused by hperoxia
#232Antigen delivery vectors and constructs
#233Process and composition for treating viral infections
#234Composition and method for treatment and chemoprevention of prostate cancer
#235Targeted oxidative therapeutic formulation
#236Targeted oxidative therapeutic formulation
#237Thrombolytic agents and methods of treatment for thrombosis
#238Injectable anesthetic formulation
#239Method for treating aspects of alcoholism, addiction and psychosis
#240Anaesthetic compositions and method for their administration
#241Methods and compounds useful to induce apoptosis in cancer cells